ArticleiGIE : innovation, investigation and insights2026
Risk factors linked to gastric intestinal metaplasia in adults from a private clinic in the Dominican Republic.
Article in iGIE : innovation, investigation and insights, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Gastric intestinal metaplasia (GIM) significantly increases the risk of developing future gastric cancer by 6-fold. This study aimed to identify the most common risk factors associated with GIM in adults who underwent EGD at a private clinic in the Dominican Republic. Methods: This retrospective cohort study examined the risk factors of GIM in adults who underwent esophagogastroduodenoscopy (EGD) at a private clinic in the Dominican Republic in 2024. Indications included dyspepsia, gastroesophageal reflux disease (GERD), surveillance of premalignant lesions, combined lower and upper gastrointestinal screening, and alarm symptoms. All procedures followed the Sydney biopsy protocol, with additional biopsy specimens from areas concerning for GIM. Experienced pathologists reviewed biopsy specimens and diagnosed GIM histologically. Patient data and biopsy results were obtained from electronic medical records, and logistic regression identified independent risk factors for GIM. Results: Of the 781 patients, 14.6% had GIM. Multivariate odds ratio (MultivOR) analysis indicated that current Conclusions: Current and past
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.